tykhr
sign in
free sign up
Ionis Pharmaceuticals Inc
Biotechnology
Healthcare
IONS
182 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
61.51
52 week high
64.40
high
63.13
52 week low
0.00
low
61.03
growth
46.33 %
previous Close
61.36
P/E ratio
market cap
6.86 B
div yield
0
usd
Jun 2025
qoq
revenue
452 M
243.43 %
net incoming
124 M
184.39 %
eps
0.00 %
175.72 %
eps surprise
391.67 %
net profit margin
27.43 %
139.00 %
operating incoming
140 M
195.33 %
net change in cash
33.11 M
49.73 %
cash on hand
2.29 B
766.79 %
cost of revenue
4.00 M
173.41 %
top